FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/03/2026
Back to search
Official data from USPTO
BICYCLE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
08/03/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
05/21/2024
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
08/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
GB
Examiner
BERGER, MAGDALENA
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Bicycletx Limited
Representatives
CHRISTINA M. LICURSI WOLF, GREENFIELD & SACKS, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for use in oncology for both solid and liquid tumoursmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disorders; pharmaceutical preparations for use as diagnosticsdiagnostic preparations for medical use; pharmaceutical preparations for use as clinical imaging agents for positron emission tomography use
Class 42
Scientific research; scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; laboratory research services in the field of oncology for both solid and liquid tumorsmetabolic diseaseurology and renal diseasecardiovascularhematologyrespiratorychronic and acute inflammatory disease and auto-immune disordersgastrointestinal diseasebacterial and viral infectious diseaseneurological and psychiatric disordersdiagnostic preparations and clinical imaging agents; providing informationconsultancy and advisory services relating to the designplanning and implementation of scientific and clinical research for others
Class 44
Medical services; medical testing for diagnostic or treatment purposes; healthcare services; pharmaceutical servicespharmaceutical compounding services; medical consulting services; advisory services relating to pharmaceuticalspharmaceutical consultation and providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; consultancy and information services relating to pharmaceuticalspharmaceutical consultation and providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical compounding services in the field of oncology; pharmaceutical compounding services in the field of ophthalmology; pharmaceutical compounding services in the field of neurology; pharmaceutical compounding services in the field of anti-infectives; pharmaceutical compounding services in connection with respiratory disease; pharmaceutical compounding services in connection with cardiovascular disease; pharmaceutical compounding services in connection with metabolic disease; pharmaceutical compounding services in connection with the treatment and/or prevention of viral infections; pharmaceutical compounding services in connection with diagnostics and imaging; pharmaceutical compounding services in connection with renal disease; pharmaceutical compounding services in connection with gastrointestinal disease; pharmaceutical compounding services in connection with muscular skeletal disease; informationconsultancy and advisory services relating to the aforesaid
Publications
History of USPTO decisions and trademark events.
40 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/03/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/27/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/26/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/09/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/09/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/02/2026
OP.T
OPPOSITION TERMINATED NO. 999999
01/02/2026
OP.D
OPPOSITION DISMISSED NO. 999999
01/02/2026
RFNT
REFUSAL PROCESSED BY IB
08/08/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/21/2025
OP.I
OPPOSITION INSTITUTED NO. 999999
07/21/2025
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
07/17/2025
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
07/17/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/26/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/26/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/26/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/26/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/26/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2025
RFNT
REFUSAL PROCESSED BY IB
12/29/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/10/2024
RFRR
REFUSAL PROCESSED BY MPU
12/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/26/2024
CNRT
NON-FINAL ACTION WRITTEN
11/25/2024
DOCK
ASSIGNED TO EXAMINER
11/16/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/15/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/15/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/15/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/10/2024
Continuous trademark protection
Get notified about every new filing that threatens BICYCLE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.